Auris Medical Holding Ltd (EARS)

0.8113 -0.02  -1.90% NASDAQ Oct 29, 20:00 USD

Auris Medical SG&A Expense (Quarterly)

View 4,000+ financial data types
Browse...
View Full Chart

SG&A Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Historical SG&A Expense (Quarterly) Data

View and export this data going back to 2013. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2018 0.4209M
Sept. 30, 2018 1.189M
June 30, 2018 1.115M
March 31, 2018 1.435M
Dec. 31, 2017 1.079M
Sept. 30, 2017 1.388M
June 30, 2017 1.254M
March 31, 2017 1.419M
Dec. 31, 2016 1.267M
Sept. 30, 2016 1.227M
June 30, 2016 1.777M
March 31, 2016 1.230M
   
Dec. 31, 2015 1.052M
Sept. 30, 2015 1.375M
June 30, 2015 1.040M
March 31, 2015 0.9766M
Dec. 31, 2014 0.0427M
Sept. 30, 2014 1.091M
June 30, 2014 0.9507M
March 31, 2014 1.914M
Dec. 31, 2013 0.3351M
Sept. 30, 2013 0.2984M
June 30, 2013 0.4901M
March 31, 2013 0.2905M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Benchmarks

Kiniksa Pharmaceuticals Ltd 9.536M
Cyclerion Therapeutics Inc 6.627M
OncoCyte Corp 5.321M

SG&A Expense (Quarterly) Range, Past 5 Years

Minimum 0.4209M Dec 2018
Maximum 1.777M Jun 2016
Average 1.220M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.